0000950170-25-101248
SEC filingTeradyne holds $339M cash, $930M RPO, $407M purchase commitments, and $1.12B buyback authorization remaining.
As of June 29, 2025, Teradyne holds $339.3M in cash and equivalents, plus $149.3M in marketable securities (short and long-term), for a total liquid position of $488.6M. Total assets are $3.76B, with shareholders' equity of $2.84B. The company has no outstanding debt (excluding operating leases), indicating a strong balance sheet. Inventory stands at $350.5M, flat compared to $298.5M at year-end 2024.
Purchase commitments for components and materials total $406.9M, with $400.8M due within one year. The company also has $930.8M in unsatisfied performance obligations (RPO), of which 86.4% is expected to be recognized in the next 12 months. Deferred revenue and customer advances are $164.4M.
Share repurchases totaled $277.3M in H1 2025 (3.0M shares at $93.67 avg), leaving $1.12B under the January 2023 $2B authorization. Dividends remain at $0.12 per share quarterly ($38.6M paid in H1). No debt was issued or repaid; the $750M revolving credit facility is undrawn. Capex was $114.4M (8.6% of revenue).
Effective March 2025, Teradyne realigned into three reportable segments: Semiconductor Test (62% of H1 revenue), Product Test (12%), and Robotics (11%). Semiconductor Test revenue declined 12.2% YoY in Q2, but maintained a 19.5% operating margin. Robotics posted an operating loss of $18.5M (margin -24.8%). Product Test grew 6.7% YoY with an 18.3% margin. Geographic mix (Note E) shows 78% of revenue from Asia Pacific, 15% from Americas, and 7% from EMEA.